X4 Pharmaceuticals, Inc.
XFOR
$3.37
$0.19126.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -27.60% | -14.80% | -24.39% | -20.02% | 108.68% |
| Total Receivables | 58.86% | -31.35% | 59.37% | 25.64% | 21.65% |
| Inventory | 2.62% | 9.66% | 15.21% | 194.22% | -- |
| Prepaid Expenses | 10.55% | -19.77% | 24.82% | -10.05% | -13.62% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -23.78% | -14.69% | -21.54% | -18.50% | 100.86% |
|
|
|||||
| Total Current Assets | -23.78% | -14.69% | -21.54% | -18.50% | 100.86% |
| Net Property, Plant & Equipment | -29.93% | -14.50% | -8.51% | -6.85% | -5.43% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -1.92% | -1.87% | -1.85% | -1.80% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -22.00% | 44.86% | -11.98% | 32.08% | 19.91% |
| Total Assets | -19.11% | -11.22% | -17.80% | -15.41% | 87.74% |
|
|
|||||
| Total Accounts Payable | -30.64% | 28.93% | 0.51% | 7.40% | -10.62% |
| Total Accrued Expenses | 3.60% | -45.18% | 18.22% | -1.44% | 46.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.99% | 4.16% | 2.37% | 4.27% | 3.44% |
| Total Finance Division Other Current Liabilities | -11.81% | -- | -- | -- | -- |
| Total Other Current Liabilities | -11.81% | -- | -- | -- | -- |
| Total Current Liabilities | -11.54% | -21.27% | 12.37% | 1.23% | 22.77% |
|
|
|||||
| Total Current Liabilities | -11.54% | -21.27% | 12.37% | 1.23% | 22.77% |
| Long-Term Debt | 0.28% | 0.27% | 0.27% | 0.26% | 36.86% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -26.51% | -21.35% | -19.75% | -13.28% | -12.60% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -63.01% | -69.51% | 18.54% | 20.61% | -66.51% |
| Total Liabilities | -5.48% | -13.86% | 4.85% | 2.05% | 4.51% |
|
|
|||||
| Common Stock & APIC | 1.26% | 0.10% | 0.44% | 0.34% | 0.49% |
| Retained Earnings | -5.00% | 0.05% | -8.37% | -8.36% | 17.15% |
| Treasury Stock & Other | -7.81% | -4.92% | -7.02% | 28.30% | -2.58% |
| Total Common Equity | -82.69% | 3.59% | -62.85% | -36.88% | 9,016.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -82.69% | 3.59% | -62.85% | -36.88% | 9,016.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -82.69% | 3.59% | -62.85% | -36.88% | 9,016.89% |
|
|
|||||